+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oligonucleotide Synthesis Market by Product Type, Synthesis Method, Scale, Application - Global Forecast to 2030- Product Image
Oligonucleotide Synthesis Market by Product Type, Synthesis Method, Scale, Application - Global Forecast to 2030- Product Image
Sale

Oligonucleotide Synthesis Market by Product Type, Synthesis Method, Scale, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337611
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Oligonucleotide Synthesis Market grew from USD 12.24 billion in 2024 to USD 14.77 billion in 2025. It is expected to continue growing at a CAGR of 20.50%, reaching USD 37.49 billion by 2030.

Setting the Stage for Oligonucleotide Synthesis Advancements

Oligonucleotide synthesis has emerged as a foundational technology driving breakthroughs across diagnostics, therapeutics, and agricultural biotechnology. The ability to construct precise nucleic acid sequences at scale underpins the rapid development of novel RNA-based vaccines, gene editing tools, and molecular probes that are redefining the frontiers of modern science.

Against this backdrop of innovation, stakeholder demand for high-purity, customizable oligonucleotides has intensified, compelling manufacturers to refine synthesis methodologies and expand production capabilities. Concurrent advances in automation, process optimization, and reagent development have collectively reduced cycle times, improved sequence fidelity, and enabled scalable manufacturing from laboratory bench to commercial facilities.

This executive summary distills the critical trends, regulatory catalysts, and competitive forces shaping the oligonucleotide synthesis landscape. It provides an integrated view of transformative shifts, tariff impacts, segmentation dynamics, regional variations, and strategic imperatives poised to influence market trajectories.

Unprecedented Transformations Reshaping Oligonucleotide Synthesis

The oligonucleotide synthesis landscape is undergoing unprecedented transformations fueled by breakthroughs in chemistry and automation. Template-independent enzymatic synthesis platforms now deliver high throughput with minimal error rates, while innovations in phosphoramidite chemistry have streamlined solid-phase and liquid-phase workflows to support rapid iteration of novel sequence designs.

Simultaneously, the advent of modified nucleotides-including locked nucleic acids and morpholino backbones-has expanded the toolkit available to developers pursuing antisense therapies and CRISPR-based gene editing. These modifications enhance stability and target affinity, driving accelerated adoption across research and therapeutic pipelines.

Beyond laboratory innovations, supply chain digitization and modular manufacturing approaches are redefining production agility. Integrated data analytics and real-time quality monitoring enable dynamic process adjustments, ensuring consistent output even as demand oscillates across applications. Collectively, these shifts are elevating performance benchmarks and compelling market participants to embrace continuous innovation.

Assessing the 2025 US Tariffs Impact on Oligonucleotide Supply Chains

The introduction of cumulative tariff measures in 2025 has created a new inflection point for the import-reliant oligonucleotide synthesis ecosystem. Increased duties on core phosphoramidites, specialty reagents, and custom sequencing services have directly affected landed costs for many manufacturers, prompting a reassessment of sourcing strategies and supplier partnerships.

To mitigate margin pressures, leading producers are accelerating localized reagent production, forging strategic alliances with regional chemical suppliers, and qualifying alternative raw materials that maintain stringent purity requirements. As a result, procurement teams have diversified their vendor portfolios, reducing concentration risk in traditional import corridors.

Looking ahead, the industry’s response will hinge on balancing cost optimization with supply continuity. Investments in nearshoring and dual-source frameworks are emerging as critical levers, while ongoing dialogue with policymakers seeks to clarify tariff harmonization and secure exemptions for research-critical imports. These developments underscore the necessity of agile supply chain management in preserving competitiveness.

Decoding Market Segments Driving Growth and Innovation

A multidimensional segmentation framework reveals the complexity and growth drivers underpinning the oligonucleotide synthesis market. Within product type, DNA oligonucleotides dominate foundational research uses and further subdivide into double-stranded constructs preferred for assembly applications and single-stranded sequences employed in PCR primers. Modified variants span chemistries such as 2'-O-methyl, locked nucleic acids, morpholino, and phosphorothioate backbones, each tailored to enhance nuclease resistance and binding affinity. Parallel to these, peptide nucleic acids offer an alternative backbone for specialized probe design, while RNA oligonucleotides encompass microRNA mimics, therapeutic mRNA constructs, and siRNA modulators.

Synthesis methodology introduces additional nuance, with enzymatic approaches split between template-dependent and template-independent paradigms, and chemical routes distinguished by H-phosphonate and phosphoramidite chemistries. The latter further branches into liquid-phase and solid-phase processing, enabling customizable scale-out options for high-throughput screening or bespoke synthesis runs.

Scale dynamics range from laboratory-scale batches optimized for R&D screening to pilot-scale production for preclinical validation and commercial-scale facilities supporting large-volume therapeutic supply. Application segments extend across agriculture-where pest control and trait development are primary focal points-to diagnostics, driven by biosensor integration, molecular imaging probes, and PCR & sequencing reagents. In research settings, functional genomics studies, gene expression analysis, and de novo gene synthesis projects leverage tailored oligonucleotides, while therapeutic pipelines capitalize on antisense, CRISPR-based, and RNA interference modalities.

Regional Dynamics Shaping Global Adoption Patterns

Regional landscapes exert pronounced influence on adoption rates, regulatory pathways, and competitive intensity. In the Americas, robust government funding initiatives, a dense network of academic institutions, and a mature pharmaceutical sector have cemented this region’s leadership in both research and commercial supply. Ongoing investments in domestic manufacturing and quality accreditation systems continue to bolster resilience amid shifting trade policies.

Europe, the Middle East, and Africa exhibit a heterogeneous tapestry of market maturity. Western European hubs benefit from streamlined regulatory frameworks and longstanding industrial collaborations, while emerging markets in the Middle East and Africa are beginning to invest in local synthesis capacity and research infrastructure. Cross-border partnerships and harmonized standards will be pivotal for unlocking these growth opportunities.

The Asia-Pacific arena is characterized by rapid capacity expansion, fueled by cost-effective manufacturing, growing demand from contract research organizations, and strategic government initiatives to advance biotechnology capabilities. Key markets such as China, India, and Japan are scaling up reagent production and investing in state-of-the-art facilities, positioning the region as a critical growth engine for global supply.

Competitive Landscape Profiles of Leading Innovators

The competitive landscape features established multinational corporations and nimble specialists jockeying for market share through differentiated service offerings and technology roadmaps. Leading players have pursued strategic acquisitions to augment their oligomer portfolios, expand geographic footprints, and integrate proprietary high-throughput platforms capable of delivering ultralong sequences with enhanced fidelity.

At the same time, agile startups and academic spin-outs are carving niches by focusing on emerging applications such as cell-free protein synthesis, immunostimulatory oligonucleotides, and highly multiplexed diagnostic panels. These innovators are leveraging proprietary chemistries, bespoke automation solutions, and deep application expertise to win targeted projects and establish early-stage collaborations with larger industry participants.

Across the spectrum, successful organizations are aligning R&D investments with end-user requirements, optimizing quality management systems, and deploying digital ordering interfaces to streamline customer engagement. As regulatory landscapes evolve, proactive compliance initiatives and transparent documentation practices have emerged as key differentiators in supplier evaluations.

Strategic Imperatives for Gaining a Competitive Edge

To secure a leadership position in the dynamic oligonucleotide synthesis market, organizations must prioritize sustained investment in platform innovation and reagent diversification. Embracing hybrid manufacturing models that combine automated enzymatic synthesis with advanced phosphoramidite workflows can unlock enhanced throughput while supporting a broader chemistry palette tailored to specific therapeutic or diagnostic applications.

Supply chain resilience is equally critical. Industry leaders should pursue dual-sourcing strategies, localize key reagent production, and engage in strategic partnerships with logistics providers to mitigate the evolving tariff environment. This multifaceted approach ensures continuity of supply and preserves margin integrity amid external disruptions.

Digital transformation represents a further strategic imperative. Integrating real-time analytics, predictive quality control, and customer-facing portals will enable more responsive order management and foster deeper end-user collaboration. Concurrently, aligning sustainability objectives-such as solvent recycling and energy-efficient processes-with product development roadmaps will resonate with environmentally conscious stakeholders and regulatory bodies.

Robust Methodological Approach Underpinning Market Insights

This analysis is grounded in a rigorous methodological framework combining primary interviews with industry executives, synthesis experts, and regulatory authorities alongside extensive secondary research. Inputs were drawn from peer-reviewed publications, patent filings, technical datasheets, and publicly available corporate disclosures to ensure a holistic perspective on technological trends and business strategies.

Quantitative data collection encompassed supplier capacity metrics, reagent cost structures, and application-specific adoption rates, which were triangulated through expert validation workshops. Segmentation logic was developed to align product, process, scale, and application dimensions with real-world decision parameters observed among leading end users.

Quality assurance protocols included multi-tiered data verification, editorial reviews, and consistency checks to confirm accuracy and relevance. While this study does not offer explicit market sizing or forecasts, it delivers a comprehensive qualitative and comparative assessment designed to inform strategic planning and investment prioritization.

Synthesis of Strategic Insights for Informed Decision Making

The oligucleotide synthesis domain continues to evolve at a rapid clip, driven by converging advances in chemistry, automation, and regulatory harmonization. Insights from this study underscore the importance of adaptable platforms capable of accommodating both standard sequences and highly modified constructs that address emerging therapeutic and diagnostic needs.

Regional and tariff-related considerations highlight the criticality of supply chain diversification and proactive policy engagement. Successful navigation of these factors demands agile procurement frameworks, localized manufacturing investments, and close collaboration with regulatory bodies to anticipate and address compliance challenges.

Collectively, the strategic imperatives and segmentation insights outlined herein offer a blueprint for decision makers to align their innovation roadmaps, optimize operational resilience, and secure sustainable growth. Armed with these findings, organizations are better equipped to capitalize on the expanding role of oligonucleotides in transforming healthcare, agriculture, and fundamental research.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • DNA Oligonucleotides
      • Double-Stranded DNA
      • Single-Stranded DNA
    • Modified Oligonucleotides
      • 2'-O-Methyl
      • Locked Nucleic Acid
      • Morpholino
      • Phosphorothioate
    • Peptide Nucleic Acids
    • RNA Oligonucleotides
      • miRNA
      • mRNA
      • siRNA
  • Synthesis Method
    • Enzymatic Synthesis
      • Template-Dependent
      • Template-Independent
    • H-Phosphonate Chemistry
    • Phosphoramidite Chemistry
      • Liquid Phase
      • Solid Phase
  • Scale
    • Commercial Scale
    • Laboratory Scale
    • Pilot Scale
  • Application
    • Agriculture
      • Pest Control
      • Trait Development
    • Diagnostics
      • Biosensors
      • Molecular Imaging
      • PCR & Sequencing
    • Research
      • Functional Genomics
      • Gene Expression Analysis
      • Gene Synthesis
    • Therapeutics
      • Antisense Therapy
      • CRISPR-Based Therapeutics
      • RNA Interference
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Eurofins Genomics SAS
  • Integrated DNA Technologies, Inc.
  • Twist Bioscience Corporation
  • GenScript Biotech Corporation
  • Bioneer Corporation
  • LGC Group Limited
  • Azenta, Inc.
  • Bio Basic Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Oligonucleotide Synthesis Market, by Product Type
8.1. Introduction
8.2. DNA Oligonucleotides
8.2.1. Double-Stranded DNA
8.2.2. Single-Stranded DNA
8.3. Modified Oligonucleotides
8.3.1. 2'-O-Methyl
8.3.2. Locked Nucleic Acid
8.3.3. Morpholino
8.3.4. Phosphorothioate
8.4. Peptide Nucleic Acids
8.5. RNA Oligonucleotides
8.5.1. miRNA
8.5.2. mRNA
8.5.3. siRNA
9. Oligonucleotide Synthesis Market, by Synthesis Method
9.1. Introduction
9.2. Enzymatic Synthesis
9.2.1. Template-Dependent
9.2.2. Template-Independent
9.3. H-Phosphonate Chemistry
9.4. Phosphoramidite Chemistry
9.4.1. Liquid Phase
9.4.2. Solid Phase
10. Oligonucleotide Synthesis Market, by Scale
10.1. Introduction
10.2. Commercial Scale
10.3. Laboratory Scale
10.4. Pilot Scale
11. Oligonucleotide Synthesis Market, by Application
11.1. Introduction
11.2. Agriculture
11.2.1. Pest Control
11.2.2. Trait Development
11.3. Diagnostics
11.3.1. Biosensors
11.3.2. Molecular Imaging
11.3.3. PCR & Sequencing
11.4. Research
11.4.1. Functional Genomics
11.4.2. Gene Expression Analysis
11.4.3. Gene Synthesis
11.5. Therapeutics
11.5.1. Antisense Therapy
11.5.2. CRISPR-Based Therapeutics
11.5.3. RNA Interference
12. Americas Oligonucleotide Synthesis Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Oligonucleotide Synthesis Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Oligonucleotide Synthesis Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Eurofins Genomics SAS
15.3.4. Integrated DNA Technologies, Inc.
15.3.5. Twist Bioscience Corporation
15.3.6. GenScript Biotech Corporation
15.3.7. Bioneer Corporation
15.3.8. LGC Group Limited
15.3.9. Azenta, Inc.
15.3.10. Bio Basic Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET MULTI-CURRENCY
FIGURE 2. OLIGONUCLEOTIDE SYNTHESIS MARKET MULTI-LANGUAGE
FIGURE 3. OLIGONUCLEOTIDE SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DOUBLE-STRANDED DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SINGLE-STRANDED DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY 2'-O-METHYL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LOCKED NUCLEIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MORPHOLINO, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHOROTHIOATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MIRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SIRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TEMPLATE-DEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TEMPLATE-INDEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY H-PHOSPHONATE CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LIQUID PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SOLID PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PEST CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TRAIT DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PCR & SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ANTISENSE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CRISPR-BASED THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 87. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 88. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 89. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 90. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 91. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 92. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 93. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 95. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 96. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 97. CANADA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 100. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 101. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 102. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 103. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 105. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 106. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 110. MEXICO OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 164. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 166. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 167. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 168. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 169. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 170. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 171. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 172. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 174. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 175. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 176. GERMANY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 177. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 179. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 180. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 181. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 182. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 183. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 184. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 185. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 187. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 188. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 189. FRANCE OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 203. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 205. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 206. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 207. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 208. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 209. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 210. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 211. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 213. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 214. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 215. ITALY OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 216. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 218. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 219. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 220. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 221. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 222. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 223. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 224. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 226. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 227. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 228. SPAIN OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 268. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 270. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 271. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 272. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 273. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 275. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 276. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 278. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 279. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 280. DENMARK OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 294. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 296. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 297. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 298. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 299. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 300. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOSPHORAMIDITE CHEMISTRY, 2018-2030 (USD MILLION)
TABLE 301. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2030 (USD MILLION)
TABLE 302. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 304. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 305. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 306. QATAR OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 307. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 309. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 310. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, 2018-2030 (USD MILLION)
TABLE 311. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2030 (USD MILLION)
TABLE 312. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 313. FINLAND OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHO

Companies Mentioned

The companies profiled in this Oligonucleotide Synthesis market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Eurofins Genomics SAS
  • Integrated DNA Technologies, Inc.
  • Twist Bioscience Corporation
  • GenScript Biotech Corporation
  • Bioneer Corporation
  • LGC Group Limited
  • Azenta, Inc.
  • Bio Basic Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 14.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 37.49 Billion
Compound Annual Growth Rate20.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

DNA Synthesis Market Size, Share & Trends Analysis Report by Service Type (Gene Synthesis, Oligonucleotide Synthesis), Length, Application (Research Development, Diagnostics), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

DNA Synthesis Market Size, Share & Trends Analysis Report by Service Type (Gene Synthesis, Oligonucleotide Synthesis), Length, Application (Research Development, Diagnostics), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Oligonucleotide Synthesis Market Industry Trends and Global Forecasts to 2035: by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-Users, Company Size and Key Geographical Regions - Product Image

Oligonucleotide Synthesis Market Industry Trends and Global Forecasts to 2035: by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-Users, Company Size and Key Geographical Regions

  • Report
  • 325 Pages
  • Global
From
Oligonucleotide Synthesis Market Report by Product, End Use, and Region 2024-2032 - Product Image

Oligonucleotide Synthesis Market Report by Product, End Use, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Oligonucleotide Synthesis - Global Strategic Business Report - Product Image

Oligonucleotide Synthesis - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Oligonucleotide Synthesis Market by Product, by Type, by Application, by End User, and By Region - Product Image

Oligonucleotide Synthesis Market by Product, by Type, by Application, by End User, and By Region

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.